Genetic Leap, Lilly partner to expedite genetic medicine development with AI

AI and RNA genetic-medicine company Genetic Leap is teaming up with pharma giant Eli Lilly to develop genetic medicine therapeutics.  According to the two companies, the partnership expands on a pilot program utilizing Genetic Leap’s RNA-targeted AI platform, designed to produce oligonucleotide drugs counter to targets chosen by Lilly in crucial therapeutic areas.  Lilly will […]

Doccla raises more than $38M to increase European expansion

Doccla, a provider of virtual ward and remote patient monitoring services, secured £35 million ($38.6 million) in an oversubscribed Series B funding round.  Lakestar led the round, with participation from Elaia and existing investors General Catalyst, which previously led its Series A round in 2022, and Speedinvest and Bertelsmann Investments, which co-led Doccla’s 2021 seed […]